CORINDUS VASCULAR ROBOTICS I's ticker is CVRS and the CUSIP is 218730109. A total of 81 filers reported holding CORINDUS VASCULAR ROBOTICS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $241,000 | +44.3% | 56,200 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $167,000 | -86.1% | 56,200 | -91.9% | 0.00% | -86.7% |
| Q1 2019 | $1,204,000 | +70.3% | 691,883 | -17.8% | 0.02% | +66.7% |
| Q4 2018 | $707,000 | +8.6% | 841,883 | +83.5% | 0.01% | +50.0% |
| Q3 2018 | $651,000 | +71.8% | 458,683 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $379,000 | -39.6% | 458,683 | 0.0% | 0.00% | -42.9% |
| Q1 2018 | $628,000 | +55.4% | 458,683 | +14.5% | 0.01% | +75.0% |
| Q4 2017 | $404,000 | -33.7% | 400,483 | 0.0% | 0.00% | -42.9% |
| Q3 2017 | $609,000 | -34.6% | 400,483 | -20.0% | 0.01% | -36.4% |
| Q2 2017 | $931,000 | +81.8% | 500,483 | +28.1% | 0.01% | +83.3% |
| Q1 2017 | $512,000 | +49.3% | 390,600 | -20.4% | 0.01% | +50.0% |
| Q4 2016 | $343,000 | +209.0% | 490,600 | +390.6% | 0.00% | +100.0% |
| Q3 2016 | $111,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 42,706,635 | $74,310,000 | 2.31% |
| HealthCor Management, L.P. | 19,981,655 | $34,768,000 | 1.40% |
| MASTERS CAPITAL MANAGEMENT LLC | 5,000,000 | $8,700,000 | 0.46% |
| EAM Global Investors LLC | 588,645 | $1,024,000 | 0.45% |
| EAM Investors, LLC | 808,156 | $1,406,000 | 0.34% |
| Schonfeld Strategic Advisors LLC | 1,800,000 | $3,132,000 | 0.11% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,998,174 | $3,476,000 | 0.04% |
| Canton Hathaway, LLC | 36,750 | $63,000 | 0.04% |
| Tibra Equities Europe Ltd | 209,885 | $365,000 | 0.04% |
| ExodusPoint Capital Management, LP | 210,127 | $366,000 | 0.03% |